{"id":131887,"date":"2024-08-23T15:50:42","date_gmt":"2024-08-23T10:20:42","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=131887"},"modified":"2024-08-23T15:52:03","modified_gmt":"2024-08-23T10:22:03","slug":"defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/","title":{"rendered":"Defensive stocks to buy now for an upside of more than 20%; Do you own any?"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2738465077\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Pharma stocks prove to be a defensive and resilient investment option for investors due to its constant market demand, high profitability, growth potential and diversification benefits. These stocks are unaffected by economic fluctuations and offer consistent dividends to investors.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1084617757\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p><strong>Here are four such defensive pharma stocks to buy with an upside potential of up to 22 percent:&nbsp;<\/strong><\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/ZYDUSLIFE\/consolidated\">Zydus LifeSciences Limited<\/a><\/strong><\/h2><p>Zydus Lifesciences operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.&nbsp;<\/p><p><strong>K R Choksey, a leading wealth management brokerage has set a target price of Rs.1,439 per share on Zydus Lifesciences Limited, with an upside potential of 22 percent.\u00a0<\/strong><\/p><div class=\"trade-content_5\" id=\"trade-421968561\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>With a market capitalization of Rs.1.19 lakh crore, the share price of the company is currently trading at Rs.1,178 per share, down by 2.62 percent from its previous closing price.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Also Read<\/strong><\/p>\n\n<figure class=\"wp-block-embed is-type-wp-embed is-provider-trade-brains wp-block-embed-trade-brains\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"1tvcVPLQCn\"><a href=\"https:\/\/tradebrains.in\/features\/defence-stock-jumps-after-acquiring-100-stake-in-kalyani-powertrain\/\">Defence stock jumps after acquiring 100% stake in Kalyani Powertrain<\/a><\/blockquote><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"&#8220;Defence stock jumps after acquiring 100% stake in Kalyani Powertrain&#8221; &#8212; Trade Brains\" src=\"https:\/\/tradebrains.in\/features\/defence-stock-jumps-after-acquiring-100-stake-in-kalyani-powertrain\/embed\/#?secret=emCtpnLuTM#?secret=1tvcVPLQCn\" data-secret=\"1tvcVPLQCn\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\n<\/div><\/figure><\/blockquote><h2 class=\"wp-block-heading has-medium-font-size\"><strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/GLENMARK\/consolidated\">Glenmark Pharmaceuticals Limited<\/a><\/strong><\/h2><p>Glenmark Pharmaceuticals is a global research-led pharmaceutical company engaged in generics, specialty, and over-the-counter (OTC) businesses. The company operates in over 80 countries.&nbsp;<\/p><p><strong>K R Choksey, a leading wealth management brokerage has set a target price of Rs.1,894 per share on Glenmark Pharmaceuticals Limited, with an upside potential of 13 percent.\u00a0<\/strong><\/p><p>With a market capitalization of Rs.47,556 crore, the share price of the company is currently trading at Rs.1,681.5 per share, rising 0.3 percent from its previous closing price.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/IPCALAB\/consolidated\">Ipca Laboratories Limited<\/a><\/strong><\/h2><p>Ipca Laboratories is a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 active pharmaceutical ingredients (APIs) across various therapeutic segments.&nbsp;<\/p><p><strong>Sharekhan, a full-service stock broker, has set a target price of Rs.1,600 per share on Ipca Laboratories Limited, with an upside potential of 15 percent.\u00a0<\/strong><\/p><div class=\"trade-content-10\" id=\"trade-2924043863\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>With a market capitalization of Rs.35,290 crore, the share price of the company is currently trading at Rs.1,390.65 per share, falling 0.87 percent from its previous closing price.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/GRANULES\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Granules India Limited<\/a><\/strong><\/h2><p>Granules India Limited is a multinational pharmaceutical company specialising in the production of off-patent drugs and operates in the contract research and manufacturing (CRAM) sector.&nbsp;<\/p><p><strong>K R Choksey, a renowned wealth management broker has set a target price of Rs.769 per share on Granules India Limited, with an upside potential of 13 percent.\u00a0<\/strong><\/p><p>With a market capitalization of Rs.16,602 crore, the share price of the company is currently trading at Rs.683.65 per share, falling 0.16 percent from its previous closing price.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by &#8211; Siddesh S Raskar\u00a0<\/strong><\/p><\/blockquote><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Also Read<\/strong><\/p>\n\n<figure class=\"wp-block-embed is-type-wp-embed is-provider-trade-brains wp-block-embed-trade-brains\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"U1J0PP1BXB\"><a href=\"https:\/\/tradebrains.in\/features\/stock-jumps-10-after-companys-promoter-buys-2-62-stake-from-fii\/\">Stock jumps 10% after company&#8217;s promoter buys 2.62% stake from FII<\/a><\/blockquote><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"&#8220;Stock jumps 10% after company&#8217;s promoter buys 2.62% stake from FII&#8221; &#8212; Trade Brains\" src=\"https:\/\/tradebrains.in\/features\/stock-jumps-10-after-companys-promoter-buys-2-62-stake-from-fii\/embed\/#?secret=AcclCKbHH9#?secret=U1J0PP1BXB\" data-secret=\"U1J0PP1BXB\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\n<\/div><\/figure><\/blockquote><h4 class=\"wp-block-heading has-medium-font-size\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-1803872664\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Pharma stocks prove to be a defensive and resilient investment option for investors due to its constant market demand, high profitability, growth potential and diversification benefits. These stocks are unaffected by economic fluctuations and offer consistent dividends to investors.&nbsp; Here are four such defensive pharma stocks to buy with an upside potential of up to [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":111747,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[21864,21863,21429,1488,12368,1486,1487,4912,12738,21865,13624,948,936,3157,20598,14843,14842],"class_list":["post-131887","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-defensive-pharma-stocks-to-buy","tag-defensive-stocks-to-buy","tag-glenmark-pharmaceuticals","tag-glenmark-pharmaceuticals-india","tag-glenmark-pharmaceuticals-latest-news","tag-glenmark-pharmaceuticals-news","tag-glenmark-pharmaceuticals-share-price","tag-granules-india","tag-granules-india-share-price","tag-ipca-laboratories","tag-ipca-laboratories-share-price","tag-stock-market","tag-stock-market-news","tag-stock-to-watch","tag-zydus-lifesciences","tag-zydus-lifesciences-latest-news","tag-zydus-lifesciences-share-price"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Defensive stocks to buy now for an upside of more than 20%; Do you own any? - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Pharma stocks prove to be a defensive and resilient investment option for investors due to its constant market demand, high profitability, growth potential and diversification benefits.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Defensive stocks to buy now for an upside of more than 20%; Do you own any?\" \/>\n<meta property=\"og:description\" content=\"Pharma stocks prove to be a defensive and resilient investment option for investors due to its constant market demand, high profitability, growth potential and diversification benefits.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-23T10:20:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-23T10:22:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/\",\"url\":\"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/\",\"name\":\"Defensive stocks to buy now for an upside of more than 20%; Do you own any? - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"datePublished\":\"2024-08-23T10:20:42+00:00\",\"dateModified\":\"2024-08-23T10:22:03+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Pharma stocks prove to be a defensive and resilient investment option for investors due to its constant market demand, high profitability, growth potential and diversification benefits.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Defensive stocks to buy now for an upside of more than 20%; Do you own any?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Defensive stocks to buy now for an upside of more than 20%; Do you own any? - Trade Brains Features","description":"Pharma stocks prove to be a defensive and resilient investment option for investors due to its constant market demand, high profitability, growth potential and diversification benefits.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/","og_locale":"en_US","og_type":"article","og_title":"Defensive stocks to buy now for an upside of more than 20%; Do you own any?","og_description":"Pharma stocks prove to be a defensive and resilient investment option for investors due to its constant market demand, high profitability, growth potential and diversification benefits.","og_url":"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-08-23T10:20:42+00:00","article_modified_time":"2024-08-23T10:22:03+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/","url":"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/","name":"Defensive stocks to buy now for an upside of more than 20%; Do you own any? - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","datePublished":"2024-08-23T10:20:42+00:00","dateModified":"2024-08-23T10:22:03+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Pharma stocks prove to be a defensive and resilient investment option for investors due to its constant market demand, high profitability, growth potential and diversification benefits.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/defensive-stocks-to-buy-now-for-an-upside-of-more-than-20-do-you-own-any\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Defensive stocks to buy now for an upside of more than 20%; Do you own any?"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/131887","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=131887"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/131887\/revisions"}],"predecessor-version":[{"id":131890,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/131887\/revisions\/131890"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/111747"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=131887"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=131887"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=131887"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}